Revelation Biosciences, Inc. (NASDAQ:REVBW – Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totaling 2,237 shares, a drop of 63.0% from the September 30th total of 6,042 shares. Based on an average daily volume of 30,036 shares, the days-to-cover ratio is presently 0.1 days.
Revelation Biosciences Price Performance
NASDAQ:REVBW remained flat at $0.01 during trading hours on Friday. Revelation Biosciences has a 52 week low of $0.00 and a 52 week high of $0.04. The business has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.01.
Revelation Biosciences Company Profile
Revelation Biosciences, Inc is a clinical-stage biotechnology company focused on developing therapies that harness the body’s innate immune system to prevent and treat disease. The company’s programs are based primarily on Gemini, its proprietary formulation of an innate immune modulator designed for administration through the nose.
Revelation’s product candidates are being investigated for potential use in respiratory and other infectious diseases, with research aimed at stimulating an early immune response in the nasal passages and airways.
Further Reading
- Five stocks we like better than Revelation Biosciences
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
- The Factories Behind AI Servers Just Raised Their Outlooks—3 Contract Manufacturers to Watch
- MarketBeat Week in Review – 10/26 – 10/30
Receive News & Ratings for Revelation Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revelation Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
